Cargando…

Correction: Total gastrectomy increases the incidence of grade III and IV toxicities in patients with gastric cancer receiving adjuvant TS-1 treatment

Detalles Bibliográficos
Autores principales:	Chou, Wen-Chi, Chang, Chia-Lun, Liu, Keng-Hao, Hsu, Jun-Te, Hsu, Hung-Chih, Shen, Wen-Chi, Hung, Yu-Shin, Cheng, Wei Hong, Chen, Jen-Shi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866252/ http://dx.doi.org/10.1186/1477-7819-11-310

Ejemplares similares

Total gastrectomy increases the incidence of grade III and IV toxicities in patients with gastric cancer receiving adjuvant TS-1 treatment
por: Chou, Wen-Chi, et al.
Publicado: (2013)

Adjuvant Chemotherapy Improves Survival in Stage III Gastric Cancer after D2 Surgery
por: Chang, Shin-Chun, et al.
Publicado: (2018)

Significance of the Glasgow Prognostic Score in Predicting the Postoperative Outcome of Patients with Stage III Gastric Cancer
por: Hsueh, Shun-Wen, et al.
Publicado: (2019)

Real-World Effectiveness of Adjuvant Oxaliplatin Chemotherapy in Stage III Colon Cancer: A Controlled Interrupted Time Series Analysis
por: Huang, Wen-Kuan, et al.
Publicado: (2021)

Protein-bound polysaccharide K prolonged overall survival in gastric cancer patients from a non-Japanese Asian country who received gastrectomy and adjuvant chemotherapy
por: Wang, Ting-Yao, et al.
Publicado: (2022)

Prognostic Value of EGFR Expression for Patients With Stage III Colorectal Cancer Receiving Fluoropyrimidine Metronomic Maintenance Therapy After Radical Resection and Adjuvant Oxaliplatin-Based Chemotherapy
por: Huang, Ching-Wen, et al.
Publicado: (2021)

Risk of cardiovascular disease among different fluoropyrimidine-based chemotherapy regimens as adjuvant treatment for resected colorectal cancer
por: Huang, Wen-Kuan, et al.
Publicado: (2022)

A Simple Risk Model to Predict Survival in Patients With Carcinoma of Unknown Primary Origin
por: Huang, Chen-Yang, et al.
Publicado: (2015)

Pemetrexed had significantly better clinical efficacy in patients with stage IV lung adenocarcinoma with susceptible EGFR mutations receiving platinum-based chemotherapy after developing resistance to the first-line gefitinib treatment
por: Yang, Chih-Jen, et al.
Publicado: (2016)

LINE-1 Methylation Status Correlates Significantly to Post-Therapeutic Recurrence in Stage III Colon Cancer Patients Receiving FOLFOX-4 Adjuvant Chemotherapy
por: Lou, Yun-Ting, et al.
Publicado: (2015)

Association of preoperative frailty and postoperative delirium in older cancer patients undergoing elective abdominal surgery: A prospective observational study in Taiwan
por: Tsai, Chun-Yi, et al.
Publicado: (2023)

Palliative gastrectomy is beneficial in selected cases of metastatic gastric cancer
por: Hsu, Jun-Te, et al.
Publicado: (2017)

Gastroesophageal Reflux Disease Symptoms after Laparoscopic Sleeve Gastrectomy: A Retrospective Study
por: Wu, Wen-Yang, et al.
Publicado: (2022)

A nomogram for predicting the probability of recurrence in patients with carcinomas located in the ampulla of Vater
por: Liu, Keng-Hao, et al.
Publicado: (2017)

Effectiveness of various treatment modalities in children with vesicoureteral reflux grades II–IV: a systematic review and network meta-analysis
por: Chang, Chia-Lun, et al.
Publicado: (2023)

Lung Metastases in Patients with Stage IV Pancreatic Cancer: Prevalence, Risk Factors, and Survival Impact
por: Liu, Keng-Hao, et al.
Publicado: (2019)

Incorporation of shear wave elastography into a prediction model in the assessment of cervical lymph nodes
por: Lo, Wu-Chia, et al.
Publicado: (2019)

Reply to Graziosi et al. Rationale in the Use of Adjuvant Chemotherapy in pT3N0M0 Gastric Cancer Resected Patients. Comment on “Chen et al. Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer. J. Pers. Med. 2023, 13, 553”
por: Chen, Yi-Fu, et al.
Publicado: (2023)

Validation and application of a prognostic model for patients with advanced pancreatic cancer receiving palliative chemotherapy
por: Huang, Pei‐Wei, et al.
Publicado: (2019)

Impact of Metformin Use on Survival in Patients with Gastric Cancer and Diabetes Mellitus Following Gastrectomy
por: Chung, Wai-Shan, et al.
Publicado: (2020)

Effect of S‐1 on survival outcomes in 838 patients with advanced pancreatic cancer: A 7‐year multicenter observational cohort study in Taiwan
por: Lai, Hsiang‐Lan, et al.
Publicado: (2019)

Risk of Severe Acute Exacerbation of Chronic HBV Infection Cancer Patients Who Underwent Chemotherapy and Did Not Receive Anti-Viral Prophylaxis
por: Shih, Chih-An, et al.
Publicado: (2015)

Over-Expression of CHD4 Is an Independent Biomarker of Poor Prognosis in Patients with Rectal Cancers Receiving Concurrent Chemoradiotherapy
por: Wang, Hui-Ching, et al.
Publicado: (2019)

A real-world study comparing perioperative chemotherapy and EGFR-tyrosine kinase inhibitors for treatment of resected stage III EGFR-mutant adenocarcinoma
por: Chen, Chieh-Lung, et al.
Publicado: (2023)

A Prognostic Model Based on Circulating Tumour Cells is Useful for Identifying the Poorest Survival Outcome in Patients with Metastatic Colorectal Cancer
por: Chou, Wen-Chi, et al.
Publicado: (2018)

Machine Learning Models to Predict the Risk of Rapidly Progressive Kidney Disease and the Need for Nephrology Referral in Adult Patients with Type 2 Diabetes
por: Hsu, Chia-Tien, et al.
Publicado: (2023)

Incidence and Risk Factors for Extremity Osteoradionecrosis after Limb-Sparing Surgery and Adjuvant Radiotherapy
por: Lu, Yun-Jui, et al.
Publicado: (2023)

Grade III or Grade IV Hypertensive Retinopathy with Severely Elevated Blood Pressure
por: Henderson, Amanda D., et al.
Publicado: (2012)

Predictors of sleep disturbance in heroin users receiving methadone maintenance therapy: a naturalistic study in Taiwan
por: Li, Dian-Jeng, et al.
Publicado: (2018)

Association of time interval between cancer diagnosis and initiation of palliative chemotherapy with overall survival in patients with unresectable pancreatic cancer
por: Lee, Shu‐Hui, et al.
Publicado: (2019)

Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer
por: Chen, Yi-Fu, et al.
Publicado: (2023)

Sequential cetuximab/bevacizumab therapy is associated with improved outcomes in patients with wild‐type KRAS exon 2 metastatic colorectal cancer
por: Hsu, Hung‐Chih, et al.
Publicado: (2019)

Antireflux mucosal intervention (ARMI) procedures for refractory gastroesophageal reflux disease: a systematic review and meta-analysis
por: Yeh, Jen-Hao, et al.
Publicado: (2022)

The Association of Uremic Toxins and Inflammation in Hemodialysis Patients
por: Hsu, Heng-Jung, et al.
Publicado: (2014)

Predictive models for short-term mortality and length of hospital stay among adults with community-onset bacteraemia before and during the COVID-19 pandemic: application of early data dynamics
por: Lee, Ching-Chi, et al.
Publicado: (2023)

Factors associated with chronic musculoskeletal pain in patients with chronic kidney disease
por: Hsu, Heng-Jung, et al.
Publicado: (2014)

Risk of Herpes Zoster in Patients with Pulmonary Tuberculosis—A Population-Based Cohort Study
por: Wang, Chih-An, et al.
Publicado: (2023)

Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study
por: Lee, Meng-Rui, et al.
Publicado: (2019)

Adjuvant radiotherapy and chemotherapy improve survival in patients with pancreatic adenocarcinoma receiving surgery: adjuvant chemotherapy alone is insufficient in the era of intensity modulation radiation therapy
por: Hsieh, Mao‐Chih, et al.
Publicado: (2018)

Reduced FEV(1) as Prognostic Factors in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors
por: Shen, Yi-Luen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l1r30qd4ishen8pbuvh7flmkga